Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today the closing of a definitive agreement to acquire the U.S. sales and distribution rights for a ...
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the issuance of U.S. Patent 8,579,865. This new patent is related to a previously issued U.S. patent 8,480,631, and ...
Add Yahoo as a preferred source to see more of our stories on Google. Antares Pharma announced its first-quarter results Wednesday morning but failed to impress the market. Shares were down around 3% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results